Federal contractor · public award history
THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Parent: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER S3GMKS8ELA16
- Awards we know about
- 27
- Typical size
- $1.10M
- Middle of their public awards
- Dollars on those awards
- $88.47M
Most of their awards we can see fall roughly between $623,884 and $1.28M.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Public award activity by year
Sum of award values in our USAspending index (not a full financial history).
- 2024$9.41M
- 2025$79.06M
Awarding agencies
- Department of Health and Human Services (25)
- Department of Veterans Affairs (2)
Industries & product codes
Award history
- Department of Health and Human Services$1.18M
BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP6
- Department of Health and Human Services$7.88M
OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)
- Department of Health and Human Services$691,578
PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC)
- Department of Health and Human Services$123,000
V105: NON-HUMAN PRIMATE ACQUISITION
- Department of Health and Human Services$57.94M
NATIONAL CORD BLOOD INVENTORY
- Department of Veterans Affairs$760,510
MED PHYSICS PEER REVIEW SERVICES
- Department of Health and Human Services$1.27M
TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER
- Department of Veterans Affairs$972,225
MEDICAL PHYSICS PEER REVIEW OF RADIATION THERAPY QUALITY ASSURANCE OPERATIONS
- Department of Health and Human Services$840,820
BASE:PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY&INTERMEDIATE BIOMARKERS TASK ORDER: TARGETING STAT3 TO PREVENT HEPATOCELLULAR CARCINOMA (HCC) ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)
- Department of Health and Human Services$1.25M
TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA
- Department of Health and Human Services—
NON-HUMAN PRIMATE ACQUISITION, TESTING, TRANSPORTATION AND HOUSING
- Department of Health and Human Services$1.16M
TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS
- Department of Health and Human Services$425,645
IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES.
- Department of Health and Human Services$1.12M
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY FOR THE PREVENTION OF BREAST CANCER
- Department of Health and Human Services$1.29M
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
- Department of Health and Human Services$932,948
TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE
- Department of Health and Human Services$1.10M
TARGETING STAT3 TO PREVENT NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
- Department of Health and Human Services$115,000
PER DIEM AND TESTING COST FOR THE NIAID AOTUS NHP COLONY
- Department of Health and Human Services—
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS (POP: 1/25/2019 - 1/24/2024)
- Department of Health and Human Services—
SQUIRREL MONKEYS, BOLIVIA, EITHER GENDER, GREATER THAN 700 GRAM, ESTABLISHED PAIRS PREFERRED, SPF (REF. N1)
- Department of Health and Human Services$171,069
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY
- Department of Health and Human Services$556,189
IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER
- Department of Health and Human Services$2.19M
IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS
- Department of Health and Human Services$1.58M
IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL
- Department of Health and Human Services$40,865
SQUIRREL MONKEY, BOLIVIAN, MIXED GENDER, SPF, IAW CONTRACT SOW AND RFQ N73
- Department of Health and Human Services$4.88M
BIOMEDICAL (BASIC)
- Department of Health and Human Services—
PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.